
Peptides
Sous-catégories appartenant à la catégorie "Peptides"
29658 produits trouvés pour "Peptides"
C19ORF47 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of C19orf47 antibody, catalog no. 70R-3346
Degré de pureté :Min. 95%OXCT2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of OXCT2 antibody, catalog no. 70R-5373
Degré de pureté :Min. 95%Neuropeptide SF (human) trifluoroacetate salt
CAS :Neuropeptide:
Neuropeptides are small signaling molecules produced and released by neurons engaged in many physiological functions. Indeed, neuropeptides act on neural substrates such as G protein-coupled receptors (GPCRs), tyrosine-kinase receptor, insuline-like peptides and also ion channels. Actions of neuropeptides result in slow-onset, long-lasting modulation of synaptic transmission.
Neuropeptide NPSF (SQAFLFQPQRF-NH2):
Neuropeptide NPSF (SQAFLFQPQRF-NH2) is part of the FMRFamide-related peptides family. Neuropeptide NPSF has shown an important role in pain regulation and plays a role of anti-opiate. Moreover, Neuropeptide NPSF seems to be implicate in variety of physiological processes such as food intake, insulin release, blood pressure regulation and electrolyte balance. Neuropeptide NPSF (SQAFLFQPQRF-NH2) is useful in opioid research.Formule :C65H94N18O15Degré de pureté :Min. 95%Masse moléculaire :1,367.55 g/molASPH Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ASPH antibody, catalog no. 70R-7074
Degré de pureté :Min. 95%DDX52 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DDX52 antibody, catalog no. 70R-4625
Degré de pureté :Min. 95%PTGER3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PTGER3 antibody, catalog no. 70R-6527
Degré de pureté :Min. 95%ITPK1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ITPK1 antibody, catalog no. 70R-3684
Degré de pureté :Min. 95%C10ORF96 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of C10orf96 antibody, catalog no. 70R-3327
Degré de pureté :Min. 95%UBE2C Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of UBE2C antibody, catalog no. 70R-5588
Degré de pureté :Min. 95%ACAT1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ACAT1 antibody, catalog no. 70R-2469
Degré de pureté :Min. 95%KHDRBS3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of KHDRBS3 antibody, catalog no. 70R-4610
Degré de pureté :Min. 95%CYP3A7 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CYP3A7 antibody, catalog no. 70R-1867
Degré de pureté :Min. 95%KLF14 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of KLF14 antibody, catalog no. 70R-8111
Degré de pureté :Min. 95%RBM14 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RBM14 antibody, catalog no. 70R-5676
Degré de pureté :Min. 95%AP3S1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of AP3S1 antibody, catalog no. 70R-9130
Degré de pureté :Min. 95%SULT2B1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SULT2B1 antibody, catalog no. 70R-2605
Degré de pureté :Min. 95%NOL5A Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of NOL5A antibody, catalog no. 70R-4804
Degré de pureté :Min. 95%Apbb1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Apbb1 antibody, catalog no. 70R-9328
Degré de pureté :Min. 95%PPIE Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PPIE antibody, catalog no. 70R-1434
Degré de pureté :Min. 95%ARL17 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ARL17 antibody, catalog no. 70R-3805
Degré de pureté :Min. 95%CX36 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CX36 antibody, catalog no. 70R-1689
Degré de pureté :Min. 95%Mettl4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Mettl4 antibody, catalog no. 70R-8799
Degré de pureté :Min. 95%MBP (84-97)
MBP (Myelin Basic Protein – UniProtKB – P04370) is a major constituent of the myelin in nerves. This protein permits the maintain of the myelin structure. MBP contains various epitopes implicated in Multiple Sclerosis.
MBP (84-97) induces EAEPRPS2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PRPS2 antibody, catalog no. 70R-4429
Degré de pureté :Min. 95%ZNF485 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF485 antibody, catalog no. 70R-8116
Degré de pureté :Min. 95%CMV pp65 (113-121)
CMV pp65 protein:
CMV pp65 (113-121) is an epitope of the main component of the enveloped subviral particle pp65 (phosphoprotein ppUL83) of Cytomegalovirus, member of herpes virus group. CMV pp65 antigens are used as target for the diagnosis of concomitant CMV end-organ disease. CMV specific cytotoxic T lymphocyte response is highly focused to pp65 in the context of HLA-A24:02.
Applications of CMV pp65 (113-121):
CMV pp65 (113-121) is used to stimulate peptide-specific CTL response and to analyze interferon γ production by flow cytometry and ELISPOT assay. CMV pp65 (113-121) contains HLA-A24 binding site and elicits CMV pp65 (113-121)-specific CTL in PBMCs which recognize pp65 expressed on CMV-infected fibroblast of HLA-A24 positive patients. CMV pp65 (113-121) might be implicated in improvement of immunotherapeutic strategies for efficient vaccine development against HCMV.ADAMTS18 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ADAMTS18 antibody, catalog no. 70R-4602
Degré de pureté :Min. 95%WDHD1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of WDHD1 antibody, catalog no. 70R-7950
Degré de pureté :Min. 95%Tetraspanin 3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TSPAN3 antibody, catalog no. 70R-7186
Degré de pureté :Min. 95%TD1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TD1 antibody, catalog no. 70R-3036
Degré de pureté :Min. 95%ZDHHC24 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZDHHC24 antibody, catalog no. 70R-7087
Degré de pureté :Min. 95%MINK1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MINK1 antibody, catalog no. 70R-7944
Degré de pureté :Min. 95%ISG20 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ISG20 antibody, catalog no. 70R-1340
Degré de pureté :Min. 95%Parathyroid Hormone (Human, 39-68)
CAS :Amino acids 39-68 of the Parathyroid Hormone (PTH) which is a peptide hormone that is secreted from the parathyroid gland in the event of abnormal serum calcium levels and it ultimately regulates calcium and phosphate levels in the body. The PTH exerts its activity through binding to the G-protein coupled receptor type 1 PTH receptor, which activates adenylate cyclase or phospholipase C thus activating pathways involved in the mediation of bone resorption and bone formation. This product is suitable for life science applications and is available as a 0.5mg vial.
Formule :C139H234N46O46Degré de pureté :Min. 95%Masse moléculaire :3,285.6 g/molKCNA10 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of KCNA10 antibody, catalog no. 70R-1497
Degré de pureté :Min. 95%SSX8 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SSX8 antibody, catalog no. 70R-9114
Degré de pureté :Min. 95%TPTE Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TPTE antibody, catalog no. 70R-1628
Degré de pureté :Min. 95%NR2F2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of NR2F2 antibody, catalog no. 20R-1220
Degré de pureté :Min. 95%ENPP2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ENPP2 antibody, catalog no. 70R-6767
Degré de pureté :Min. 95%NEURL Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of NEURL antibody, catalog no. 70R-5243
Degré de pureté :Min. 95%RGD1307041 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RGD1307041 antibody, catalog no. 70R-9487
Degré de pureté :Min. 95%JOSD2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of JOSD2 antibody, catalog no. 70R-4142
Degré de pureté :Min. 95%NYLAWYQQKPGK* - SIL Adalimumab signature peptide quantifier
SIL peptide for Adalimumab detection and quantification
Angiotensin II heavy
Angiotensin II plays an essential role in the maintenance of blood pressure and blood volume. It is a peptide hormone that causes vasoconstriction, a sensation of thirst, and stimulation of the adrenal cortex and aldosterone.
Derived from the cleavage of angiotensin I by the angiotensin converting enzyme, angiotensin II is involved in the renin-angiotensin system (RAS).
Angiotensin II is the subject of much scientific research and is already the target of many anti-hypertensive drugs (ACE inhibitors, ARBs or AT1 receptor antagonists).GTPBP9 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GTPBP9 antibody, catalog no. 70R-4825
Degré de pureté :Min. 95%TRPM3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TRPM3 antibody, catalog no. 70R-1517
Degré de pureté :Min. 95%JMJD1B Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of JMJD1B antibody, catalog no. 20R-1218
Degré de pureté :Min. 95%
